Pretreatment with dexmedetomidine exerted neuroprotective effects in a model of cerebral ischemia-reperfusion by inhibiting the TLR4/NF-κB pathway and reducing inflammatory damage [36]. The gene discussed is TLR4; the disease is Cerebral ischemia.